Robert J Kreitman

8PUBLICATIONS
60CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)Cardiovascular medicine and haematology not elsewhere classifiedApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 04, 2026
Chimeric antigen receptor T cells against the IGHV4-34 B cell receptor specifically eliminate neoplastic and autoimmune B cells.

Ivan J Cohen, Audrey C Bochi-Layec, Jean Lemoine

|Jul 16, 2025
Complete Response in Hairy Cell Leukemia to Anti-CD22 CAR T-Cell Therapy.

Robert J Kreitman, Brett Schroeder, Evgeny Arons

|Sep 20, 2023
COVID-19 in patients with classic and variant hairy cell leukemia.

Robert J Kreitman, Theresa Yu, Lacey James

|Sep 07, 2022
Development of a distributed international patient data registry for hairy cell leukemia.

Leslie A Andritsos, Mirela Anghelina, Jasmine Neal

|Nov 27, 2021
Immunotoxins: From Design to Clinical Application.

Robert J Kreitman, Ira Pastan

|Oct 04, 2021
Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variant.

Dai Chihara, Evgeny Arons, Maryalice Stetler-Stevenson

Pageof 2